| 参考文献 [1] Janjua SA, Khachemoune A, Guldbakke KK. Piebaldism: a case report and a concise review of the literature. Cutis, 2007,80(5):411-414. [2] Tomita Y, Miyamura Y, Kono M, et al. Molecular bases of congenital hypopigmentary disorders in humans and oculocutaneous albinism 1 in Japan. Pigment Cell Res, 2000,13 Suppl 8:130-134. [3] Kimura S, Kawakami T, Kawa Y, et al. Bcl-2 reduced and fas activated by the inhibition of stem cell factor/KIT signaling in murine melanocyte precursors. J Invest Dermatol, 2005,124(1):229-234. [4] Spritz RA, Giebel LB, Holmes SA. Dominant negative and loss of function mutations of the c-kit (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism. Am J Hum Genet, 1992,50(2):261-269 [5] Murakami T, Hosomi N, Oiso N, et al. Analysis of KIT, SCF, and initial screening of SLUG in patients with piebaldism. J Invest Dermatol, 2005,124(3):670-672. [6] Bondanza S, Bellini M, Roversi G, et al. Piebald trait: implication of kit mutation on in vitro melanocyte survival and on the clinical application of cultured epidermal autografts. J Invest Dermatol, 2007,127(3):676-686. [7] Murakami T, Fukai K, Oiso N, et al. New KIT mutations in patients with piebaldism. J Dermatol Sci, 2004,35(1):29-33. [8] Lin ZM, Xu Z, Bu DF, et al. New mutations of KIT gene in two Chinese patients with piebaldism. Br J Dermatol, 2006,155(6):1303-1304. [9] Richards KA, Fukai K, Oiso N, et al. A novel KIT mutation results in piebaldism with progressive depigmentation. J Am Acad Dermatol, 2001,44(2):288-292. [10] Syrris P, Malik NM, Murday VA, et al. Three novel mutations of the proto-oncogene KIT cause human piebaldism. Am J Med Genet, 2000,95(1):79-81. [11] Syrris P, Heathcote K, Carrozzo R, et al. Human piebaldism: six novel mutations of the proto-oncogene KIT. Hum Mutat, 2002,20(3):234. [12] Ezoe K, Holmes SA, Ho L, et al. Novel mutations and deletions of the KIT (steel factor receptor) gene in human piebaldism. Am J Hum Genet, 1995,56(1):58-66. |
